Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Collplant Biotechnologies Ltd - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CLGN
Nasdaq
8731
https://www.collplant.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Collplant Biotechnologies Ltd
CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
- Nov 29th, 2023 12:00 pm
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
- Nov 9th, 2023 1:00 pm
Will CollPlant Biotechnologies (NASDAQ:CLGN) Spend Its Cash Wisely?
- Nov 3rd, 2023 10:10 am
CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler
- Nov 1st, 2023 11:00 am
Shareholders in CollPlant Biotechnologies (NASDAQ:CLGN) are in the red if they invested three years ago
- Oct 5th, 2023 12:14 pm
CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative
- Sep 21st, 2023 11:00 am
CollPlant to Present at the H.C. Wainwright Annual Growth Conference
- Sep 5th, 2023 11:00 am
Results: CollPlant Biotechnologies Ltd. Beat Earnings Expectations And Analysts Now Have New Forecasts
- Aug 27th, 2023 12:18 pm
CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
- Aug 24th, 2023 11:00 am
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 SECOND QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
- Aug 9th, 2023 12:00 pm
CollPlant Achieves Milestone and To Receive $10 Million From AbbVie in Accordance with its Regenerative Dermal Filler Product Collaboration Agreement
- Jun 26th, 2023 11:00 am
CollPlant Biotechnologies Announces First Quarter Financial Results For 2023 and Provides Corporate Update
- May 24th, 2023 11:00 am
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FIRST QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
- May 2nd, 2023 1:00 pm
Stratasys and CollPlant Unite Technologies to Transform Healthcare with Industrial-Scale Bioprinting of Tissues and Organs
- Apr 4th, 2023 12:26 pm
Collplant Biotechnologies Announces Full-Year Financial Results For 2022 and Provides Corporate Update
- Mar 29th, 2023 11:00 am
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2022 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
- Mar 14th, 2023 11:00 am
CollPlant Issues Letter to Shareholders
- Jan 24th, 2023 12:00 pm
CollPlant Announces Successful Pre-Clinical Results in 3D Bioprinted Regenerative Breast Implants Porcine Study and Full Achievement of Objectives
- Jan 4th, 2023 12:00 pm
CollPlant Enriches Portfolio of rhCollagen-Based Bioinks with Launch of Collink.3DTM 50L in Powder Form
- Jan 3rd, 2023 12:00 pm
We Think CollPlant Biotechnologies (NASDAQ:CLGN) Can Afford To Drive Business Growth
- Dec 12th, 2022 2:50 pm
Scroll